首页 > 最新文献

Obstetrics, Gynaecology and Reproductive Medicine最新文献

英文 中文
Outpatient management of severe ovarian hyperstimulation syndrome 严重卵巢过度刺激综合征的门诊治疗
Q3 Medicine Pub Date : 2024-08-20 DOI: 10.1016/j.ogrm.2024.08.004
Lewis Nancarrow, Andrew Drakeley
Ovarian hyperstimulation (OHSS) is an iatrogenic complication, which commonly occurs after controlled ovarian stimulation (COS) in in-vitro fertilization (IVF) cycles. Most patients experience mild to moderate OHSS and can be managed safely in an outpatient setting with regular monitoring from their fertility treatment centre. However, severe OHSS has traditionally been managed on an inpatient basis to ensure regular monitoring and bloods can be performed to ensure there is no deterioration in the patient's condition. The mainstay of treatment remains supportive care even in severe cases of OHSS. This spotlight article aims to show that, with correct patient selection, most patients can be managed safely and effectively in an outpatient setting.
卵巢过度刺激(OHSS)是一种先天性并发症,通常发生在体外受精(IVF)周期中的控制性卵巢刺激(COS)之后。大多数患者都会出现轻度至中度的促排卵过多症(OHSS),可在门诊环境中通过生殖治疗中心的定期监测进行安全处理。然而,重度OHSS传统上需要住院治疗,以确保定期监测和抽血,确保患者的病情没有恶化。即使是严重的卵巢功能不全症,治疗的主要方式仍然是支持性护理。这篇聚焦文章旨在说明,只要患者选择正确,大多数患者都可以在门诊环境中得到安全有效的治疗。
{"title":"Outpatient management of severe ovarian hyperstimulation syndrome","authors":"Lewis Nancarrow,&nbsp;Andrew Drakeley","doi":"10.1016/j.ogrm.2024.08.004","DOIUrl":"10.1016/j.ogrm.2024.08.004","url":null,"abstract":"<div><div>Ovarian hyperstimulation (OHSS) is an iatrogenic complication, which commonly occurs after controlled ovarian stimulation (COS) in in-vitro fertilization (IVF) cycles. Most patients experience mild to moderate OHSS and can be managed safely in an outpatient setting with regular monitoring from their fertility treatment centre. However, severe OHSS has traditionally been managed on an inpatient basis to ensure regular monitoring and bloods can be performed to ensure there is no deterioration in the patient's condition. The mainstay of treatment remains supportive care even in severe cases of OHSS. This spotlight article aims to show that, with correct patient selection, most patients can be managed safely and effectively in an outpatient setting.</div></div>","PeriodicalId":53410,"journal":{"name":"Obstetrics, Gynaecology and Reproductive Medicine","volume":"34 11","pages":"Pages 312-315"},"PeriodicalIF":0.0,"publicationDate":"2024-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142527081","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Management of connective tissue disorders and dermatological disorders in pregnancy 妊娠期结缔组织疾病和皮肤病的管理
Q3 Medicine Pub Date : 2024-08-17 DOI: 10.1016/j.ogrm.2024.07.003
Frances Hills
Connective tissue, rheumatological and dermatological conditions affect a large proportion of the pregnant population and have important implications for women and their babies. Some conditions are chronic but may occur de novo in pregnancy whereas some are seen only during pregnancy. Multidisciplinary care is essential to maximise fetal and maternal outcomes, since many of these women require immunosuppressive treatment and close monitoring of their pregnancies. The development of biological therapies has revolutionised treatment of many connective tissue and arthritic diseases, allowing both more targeted treatments and an increase in treatment options. Their impact on fertility is minimal compared to older treatments and hence more women are able to conceive. With new treatments there will always be concerns about safety in pregnancy but concerns around neonatal immunosuppression have largely been unfounded and the benefits of continuing medication are significant. This article uses four cases to illustrate the challenges of management.
结缔组织、风湿病和皮肤病影响着很大一部分孕妇,并对妇女及其胎儿产生重要影响。有些疾病是慢性的,但可能会在怀孕期间重新出现,而有些则只在怀孕期间出现。为了最大限度地改善胎儿和母体的预后,多学科护理是必不可少的,因为其中许多妇女需要接受免疫抑制治疗并对妊娠进行密切监测。生物疗法的发展彻底改变了许多结缔组织和关节炎疾病的治疗方法,使治疗更有针对性,治疗选择也更多。与旧的治疗方法相比,生物疗法对生育能力的影响微乎其微,因此有更多的妇女能够怀孕。对于新的治疗方法,人们总是会担心妊娠的安全性,但对新生儿免疫抑制的担忧在很大程度上是没有根据的,而且继续用药的益处也很大。本文通过四个病例来说明管理方面的挑战。
{"title":"Management of connective tissue disorders and dermatological disorders in pregnancy","authors":"Frances Hills","doi":"10.1016/j.ogrm.2024.07.003","DOIUrl":"10.1016/j.ogrm.2024.07.003","url":null,"abstract":"<div><div>Connective tissue, rheumatological and dermatological conditions affect a large proportion of the pregnant population and have important implications for women and their babies. Some conditions are chronic but may occur de novo in pregnancy whereas some are seen only during pregnancy. Multidisciplinary care is essential to maximise fetal and maternal outcomes, since many of these women require immunosuppressive treatment and close monitoring of their pregnancies. The development of biological therapies has revolutionised treatment of many connective tissue and arthritic diseases, allowing both more targeted treatments and an increase in treatment options. Their impact on fertility is minimal compared to older treatments and hence more women are able to conceive. With new treatments there will always be concerns about safety in pregnancy but concerns around neonatal immunosuppression have largely been unfounded and the benefits of continuing medication are significant. This article uses four cases to illustrate the challenges of management.</div></div>","PeriodicalId":53410,"journal":{"name":"Obstetrics, Gynaecology and Reproductive Medicine","volume":"34 10","pages":"Pages 278-285"},"PeriodicalIF":0.0,"publicationDate":"2024-08-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142311624","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Surgical management of pelvic organ prolapse 盆腔器官脱垂的手术治疗
Q3 Medicine Pub Date : 2024-08-01 DOI: 10.1016/j.ogrm.2024.05.003
Navjeet Chohan, Veenu Tyagi

Pelvic organ prolapse (POP) is a common condition and is thought to affect approximately 40% of women over the age of 50, with prevalence increasing with age. 1 in 10 women will undergo surgery during their lifetime. Symptomatic women can be offered supervized pelvic floor exercises supported by Specialist Pelvic Floor Physiotherapists, vaginal pessary management or surgical management. This article covers comprehensive assessment, preoperative considerations to support shared decision making, and clinical governance surrounding surgical management of prolapse. It also provides a summary of different surgical techniques for both vaginal and abdominal approach for prolapse.

盆腔器官脱垂(POP)是一种常见疾病,据认为约有 40% 的 50 岁以上女性会受到影响,而且患病率会随着年龄的增长而增加。每 10 位女性中就有 1 位会在一生中接受手术治疗。有症状的妇女可在专业盆底物理治疗师的支持下进行有指导的盆底锻炼、阴道栓剂治疗或手术治疗。本文介绍了综合评估、支持共同决策的术前注意事项以及围绕脱垂手术治疗的临床管理。文章还总结了阴道和腹部治疗脱垂的不同手术技巧。
{"title":"Surgical management of pelvic organ prolapse","authors":"Navjeet Chohan,&nbsp;Veenu Tyagi","doi":"10.1016/j.ogrm.2024.05.003","DOIUrl":"10.1016/j.ogrm.2024.05.003","url":null,"abstract":"<div><p>Pelvic organ prolapse (POP) is a common condition and is thought to affect approximately 40% of women over the age of 50, with prevalence increasing with age. 1 in 10 women will undergo surgery during their lifetime. Symptomatic women can be offered supervized pelvic floor exercises supported by Specialist Pelvic Floor Physiotherapists, vaginal pessary management or surgical management. This article covers comprehensive assessment, preoperative considerations to support shared decision making, and clinical governance surrounding surgical management of prolapse. It also provides a summary of different surgical techniques for both vaginal and abdominal approach for prolapse.</p></div>","PeriodicalId":53410,"journal":{"name":"Obstetrics, Gynaecology and Reproductive Medicine","volume":"34 8","pages":"Pages 218-228"},"PeriodicalIF":0.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141950376","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The fetal anomaly screening scan: an international perspective 胎儿异常筛查扫描:国际视角
Q3 Medicine Pub Date : 2024-08-01 DOI: 10.1016/j.ogrm.2024.05.002
Hessa Hazeem Al Suwaidi, Reham Mahmoud Abas Abdelhalem, Andrea Kaelin Agten

Fetal structural anomalies, affecting up to 3% of pregnancies, can be a major concern for expectant parents. Ultrasound screening has become an essential part of prenatal care, offering early detection of birth defects and empowering parents with information for reproductive decision making. While first-trimester scans are becoming more informative, the second-trimester scan remains the cornerstone of anomaly detection. Technological advancements, and the use of additional tools like MRI, are further enhancing our ability to ensure a healthy outcome for both mother and baby. Advancements have enabled detection of around half of all major anomalies in the first trimester (11–13+6) weeks. Professional societies recommend the second-trimester anatomy scan (18–22 weeks) as the gold standard for anomaly detection. The fetal anomaly scan boasts a high detection rate for major structural malformations, ranging from 15% to exceeding 90% in some cases. Detection rates vary depending on the organ system being examined. Equipment settings and sonographer experience play a role in accuracy. Whilst not 100% effective, the scan is safe and valuable. It empowers informed decision-making and can improve some pregnancy outcomes by enabling early detection and management. This allows for interventions, planning for delivery at the right time and place, and emotional preparation for parents. However, it is crucial to understand the limitations of the scan and the possibility of false positives or missed anomalies.

多达 3% 的孕妇会出现胎儿结构异常,这可能是准父母们最担心的问题。超声波筛查已成为产前保健的重要组成部分,它能及早发现先天缺陷,并为父母提供有关生育决策的信息。虽然第一孕期扫描的信息量越来越大,但第二孕期扫描仍是异常检测的基石。技术的进步以及核磁共振成像等其他工具的使用,进一步提高了我们确保母婴健康的能力。技术的进步使我们能够在妊娠头三个月(11-13+6)周检测出大约一半的重大异常。专业协会建议将第二孕期解剖扫描(18-22 周)作为异常检测的黄金标准。胎儿异常扫描对主要结构畸形的检出率很高,从 15%到超过 90%不等。检测率因检查的器官系统而异。设备设置和超声技师的经验对准确率也有影响。虽然不是百分之百有效,但扫描是安全和有价值的。它有助于做出明智的决策,并能通过早期检测和管理改善某些妊娠结局。这样就可以进行干预,在正确的时间和地点计划分娩,并为父母做好情感准备。然而,了解扫描的局限性以及出现假阳性或遗漏异常的可能性至关重要。
{"title":"The fetal anomaly screening scan: an international perspective","authors":"Hessa Hazeem Al Suwaidi,&nbsp;Reham Mahmoud Abas Abdelhalem,&nbsp;Andrea Kaelin Agten","doi":"10.1016/j.ogrm.2024.05.002","DOIUrl":"10.1016/j.ogrm.2024.05.002","url":null,"abstract":"<div><p>Fetal structural anomalies, affecting up to 3% of pregnancies, can be a major concern for expectant parents. Ultrasound screening has become an essential part of prenatal care, offering early detection of birth defects and empowering parents with information for reproductive decision making. While first-trimester scans are becoming more informative, the second-trimester scan remains the cornerstone of anomaly detection. Technological advancements, and the use of additional tools like MRI, are further enhancing our ability to ensure a healthy outcome for both mother and baby. Advancements have enabled detection of around half of all major anomalies in the first trimester (11–13+6) weeks. Professional societies recommend the second-trimester anatomy scan (18–22 weeks) as the gold standard for anomaly detection. The fetal anomaly scan boasts a high detection rate for major structural malformations, ranging from 15% to exceeding 90% in some cases. Detection rates vary depending on the organ system being examined. Equipment settings and sonographer experience play a role in accuracy. Whilst not 100% effective, the scan is safe and valuable. It empowers informed decision-making and can improve some pregnancy outcomes by enabling early detection and management. This allows for interventions, planning for delivery at the right time and place, and emotional preparation for parents. However, it is crucial to understand the limitations of the scan and the possibility of false positives or missed anomalies.</p></div>","PeriodicalId":53410,"journal":{"name":"Obstetrics, Gynaecology and Reproductive Medicine","volume":"34 8","pages":"Pages 213-217"},"PeriodicalIF":0.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141950375","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Self-management of vaginal pessaries for prolapse: the TOPSY trial key findings 阴道塞药治疗脱垂的自我管理:TOPSY 试验的主要发现
Q3 Medicine Pub Date : 2024-08-01 DOI: 10.1016/j.ogrm.2024.05.004

Women with symptomatic pelvic organ prolapse are offered a choice of conservative and surgical treatment options. Two thirds of women choose a vaginal pessary, a support device inserted in the vagina. This article reports the finding of a randomized controlled trial published in 2023 evaluating the cost-effectiveness of self-management of pessary compared to clinic-based care. Women were recruited in 21 centres across the UK and 340 women were randomized to pessary self-management or clinic-based care. The primary outcome measure was prolapse-specific quality of life and secondary outcomes were generic quality of life, pelvic floor symptoms, sexual function, self-efficacy, pessary complications, pessary use and pessary confidence. Participants’ health care resource use was measured. The trial showed that at 18 month follow-up self-management was not associated with better or worse quality of life than clinic-based care. Women in the self-management group reported fewer pessary complications and lower healthcare resource use.

有症状的盆腔器官脱垂妇女可以选择保守治疗和手术治疗。三分之二的妇女会选择阴道栓,一种插入阴道的支撑装置。本文报告了 2023 年发表的一项随机对照试验的结果,该试验评估了自我管理膀胱塞与诊所护理相比的成本效益。英国 21 个中心招募了 340 名妇女,并随机分配她们接受泌尿器自我管理或诊所护理。主要结果是脱垂特异性生活质量,次要结果是一般生活质量、盆底症状、性功能、自我效能、栓剂并发症、栓剂使用和栓剂信心。对参与者的医疗资源使用情况进行了测量。试验结果表明,在 18 个月的随访中,与诊所护理相比,自我管理与更好或更差的生活质量并无关联。自我管理组的妇女报告的阴道塞并发症较少,使用的医疗资源也较少。
{"title":"Self-management of vaginal pessaries for prolapse: the TOPSY trial key findings","authors":"","doi":"10.1016/j.ogrm.2024.05.004","DOIUrl":"10.1016/j.ogrm.2024.05.004","url":null,"abstract":"<div><p><span>Women with symptomatic pelvic organ prolapse are offered a choice of conservative and surgical treatment options. Two thirds of women choose a vaginal </span>pessary<span>, a support device inserted in the vagina. This article reports the finding of a randomized controlled trial<span><span> published in 2023 evaluating the cost-effectiveness of self-management of pessary compared to clinic-based care. Women were recruited in 21 centres across the UK and 340 women were randomized to pessary self-management or clinic-based care. The primary outcome measure was prolapse-specific quality of life and secondary outcomes were generic quality of life, </span>pelvic floor<span> symptoms, sexual function, self-efficacy, pessary complications, pessary use and pessary confidence. Participants’ health care resource use was measured. The trial showed that at 18 month follow-up self-management was not associated with better or worse quality of life than clinic-based care. Women in the self-management group reported fewer pessary complications and lower healthcare resource use.</span></span></span></p></div>","PeriodicalId":53410,"journal":{"name":"Obstetrics, Gynaecology and Reproductive Medicine","volume":"34 8","pages":"Pages 229-231"},"PeriodicalIF":0.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141408278","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Self-assessment questions 自我评估问题
Q3 Medicine Pub Date : 2024-08-01 DOI: 10.1016/j.ogrm.2024.05.005
Anna Richmond
{"title":"Self-assessment questions","authors":"Anna Richmond","doi":"10.1016/j.ogrm.2024.05.005","DOIUrl":"10.1016/j.ogrm.2024.05.005","url":null,"abstract":"","PeriodicalId":53410,"journal":{"name":"Obstetrics, Gynaecology and Reproductive Medicine","volume":"34 8","pages":"Pages 232-233"},"PeriodicalIF":0.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141950377","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fertility care for persons considering gender transition 为考虑性别转换者提供生育护理
Q3 Medicine Pub Date : 2024-08-01 DOI: 10.1016/j.ogrm.2024.07.004
Ephia Yasmin
Referrals to the gender identity development service and gender identity clinics are increasing. Gender-affirming medical interventions can adversely impact on the fertility potential of the individual. The possible fertility impact of various treatments such as gonadotropin hormone releasing hormone agonists and cross over hormones, and surgery of genitalia and reproductive organs, should be discussed. An opportunity should be provided to discuss options for fertility preservation and patients should be assisted in decision making. It should be appreciated that transgender individuals have an increased incidence of mental health problems, and that there are currently many barriers to optimal care. Oocyte and spermatozoa cryopreservation provide options for biological parenthood.
转诊到性别认同发展服务和性别认同诊所的人数正在增加。确认性别的医疗干预措施可能会对个人的生育潜力产生不利影响。应讨论促性腺激素释放激素激动剂和交叉激素等各种治疗方法以及生殖器和生殖器官手术可能对生育产生的影响。应提供机会讨论保留生育能力的方案,并协助患者做出决定。应当认识到,变性人的心理健康问题发生率会增加,而且目前在优化护理方面存在许多障碍。卵细胞和精子冷冻保存为生儿育女提供了选择。
{"title":"Fertility care for persons considering gender transition","authors":"Ephia Yasmin","doi":"10.1016/j.ogrm.2024.07.004","DOIUrl":"10.1016/j.ogrm.2024.07.004","url":null,"abstract":"<div><div>Referrals to the gender identity development service and gender identity clinics are increasing. Gender-affirming medical interventions can adversely impact on the fertility potential of the individual. The possible fertility impact of various treatments such as gonadotropin hormone releasing hormone agonists and cross over hormones, and surgery of genitalia and reproductive organs, should be discussed. An opportunity should be provided to discuss options for fertility preservation and patients should be assisted in decision making. It should be appreciated that transgender individuals have an increased incidence of mental health problems, and that there are currently many barriers to optimal care. Oocyte and spermatozoa cryopreservation provide options for biological parenthood.</div></div>","PeriodicalId":53410,"journal":{"name":"Obstetrics, Gynaecology and Reproductive Medicine","volume":"34 10","pages":"Pages 286-288"},"PeriodicalIF":0.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142311625","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antenatal screening in the UK 英国的产前筛查
Q3 Medicine Pub Date : 2024-08-01 DOI: 10.1016/j.ogrm.2024.05.001
Judith Moore, Rawia Fatouta, Danielle Christian

The process of screening aims to reduce the burden of disease. In pregnancy this is relevant to both the mother and her baby. There are national screening programmes for infectious disease, haemoglobinopathy and fetal anomalies, all of which have the potential to reduce the life-long burden of disease in the newborn. But screening extends beyond these programmes and when risk factors are identified, interventions might be instigated to reduce the impact of disease on pregnancy outcomes. This article reviews screening in its broadest sense. It describes the various screening opportunities and considers the actions that can be taken to optimize the health of the mother and her baby. The process of screening continues throughout pregnancy, in the same way that risks evolve as pregnancy progresses.

筛查过程旨在减少疾病负担。在怀孕期间,这既关系到母亲,也关系到婴儿。目前已有针对传染病、血红蛋白病和胎儿畸形的全国性筛查计划,所有这些计划都有可能减少新生儿终身的疾病负担。但筛查的范围远不止这些计划,一旦发现风险因素,就可以采取干预措施,减少疾病对妊娠结局的影响。本文从广义上回顾了筛查工作。它描述了各种筛查机会,并考虑了可以采取哪些行动来优化母婴健康。筛查过程贯穿整个孕期,就像风险会随着孕期的进展而变化一样。
{"title":"Antenatal screening in the UK","authors":"Judith Moore,&nbsp;Rawia Fatouta,&nbsp;Danielle Christian","doi":"10.1016/j.ogrm.2024.05.001","DOIUrl":"10.1016/j.ogrm.2024.05.001","url":null,"abstract":"<div><p><span><span>The process of screening aims to reduce the burden of disease. In pregnancy this is relevant to both the mother and her baby. There are national screening programmes for infectious disease, haemoglobinopathy and </span>fetal anomalies, all of which have the potential to reduce the life-long burden of disease in the </span>newborn. But screening extends beyond these programmes and when risk factors are identified, interventions might be instigated to reduce the impact of disease on pregnancy outcomes. This article reviews screening in its broadest sense. It describes the various screening opportunities and considers the actions that can be taken to optimize the health of the mother and her baby. The process of screening continues throughout pregnancy, in the same way that risks evolve as pregnancy progresses.</p></div>","PeriodicalId":53410,"journal":{"name":"Obstetrics, Gynaecology and Reproductive Medicine","volume":"34 8","pages":"Pages 203-212"},"PeriodicalIF":0.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141950374","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The management of pelvic floor dysfunction in pregnancy 孕期盆底功能障碍的治疗
Q3 Medicine Pub Date : 2024-07-31 DOI: 10.1016/j.ogrm.2024.07.001
Rayan Mohamed-Ahmed, Angie Rantell, George Araklitis
Physiological changes in pregnancy can trigger or worsen a variety of pelvic floor symptoms, including stress incontinence, overactive bladder, stress incontinence and prolapse. In order to minimize both physical and psychological morbidity in the short and long term, it is important for clinicians to appropriately stratify individual risk scores and identify and manage pelvic floor disorders during pregnancy. There has been an introduction of perinatal pelvic health services as part of a government review of pelvic health in pregnancy, which aim to prevent pelvic floor dysfunction following pregnancy but identifying women at risk and referring them onwards for support from physiotherapists or specialist nurses and midwives.
This review article aims to discuss the assessment tools, government initiatives and management options for common pelvic floor disorders during pregnancy.
妊娠期的生理变化会引发或加重各种盆底症状,包括压力性尿失禁、膀胱过度活动症、压力性尿失禁和脱垂。为了最大限度地降低短期和长期的生理和心理发病率,临床医生必须对个人风险评分进行适当分层,并在孕期识别和控制盆底功能紊乱。作为政府妊娠期盆腔健康审查的一部分,围产期盆腔健康服务已被引入,其目的是预防妊娠后出现盆底功能障碍,同时识别有风险的妇女,并转介她们接受物理治疗师或专科护士和助产士的支持。
{"title":"The management of pelvic floor dysfunction in pregnancy","authors":"Rayan Mohamed-Ahmed,&nbsp;Angie Rantell,&nbsp;George Araklitis","doi":"10.1016/j.ogrm.2024.07.001","DOIUrl":"10.1016/j.ogrm.2024.07.001","url":null,"abstract":"<div><div>Physiological changes in pregnancy can trigger or worsen a variety of pelvic floor symptoms, including stress incontinence, overactive bladder, stress incontinence and prolapse. In order to minimize both physical and psychological morbidity in the short and long term, it is important for clinicians to appropriately stratify individual risk scores and identify and manage pelvic floor disorders during pregnancy. There has been an introduction of perinatal pelvic health services as part of a government review of pelvic health in pregnancy, which aim to prevent pelvic floor dysfunction following pregnancy but identifying women at risk and referring them onwards for support from physiotherapists or specialist nurses and midwives.</div><div>This review article aims to discuss the assessment tools, government initiatives and management options for common pelvic floor disorders during pregnancy.</div></div>","PeriodicalId":53410,"journal":{"name":"Obstetrics, Gynaecology and Reproductive Medicine","volume":"34 10","pages":"Pages 267-270"},"PeriodicalIF":0.0,"publicationDate":"2024-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142311622","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Self-assessment questions 自我评估问题
Q3 Medicine Pub Date : 2024-07-31 DOI: 10.1016/j.ogrm.2024.07.005
Anna Richmond
{"title":"Self-assessment questions","authors":"Anna Richmond","doi":"10.1016/j.ogrm.2024.07.005","DOIUrl":"10.1016/j.ogrm.2024.07.005","url":null,"abstract":"","PeriodicalId":53410,"journal":{"name":"Obstetrics, Gynaecology and Reproductive Medicine","volume":"34 10","pages":"Pages 289-291"},"PeriodicalIF":0.0,"publicationDate":"2024-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142311626","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Obstetrics, Gynaecology and Reproductive Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1